Global (United States, European Union and China) Active Pharmaceutical Ingredients(API) Market Research Report 2019-2025


    Table of Contents

      1 Report Overview

      • 1.1 Study Scope
      • 1.2 Major Manufacturers Covered in This Report
      • 1.3 Market Segment by Type
        • 1.3.1 Global Active Pharmaceutical Ingredients(API) Market Size Growth Rate by Type (2019-2025)
        • 1.3.2 Synthetic APIs
        • 1.3.3 Biotech APIs
      • 1.4 Market Segment by Application
        • 1.4.1 Global Active Pharmaceutical Ingredients(API) Market Share by Application (2019-2025)
        • 1.4.2 Oncology
        • 1.4.3 Diabetes
        • 1.4.4 Cardiovascular Disease
        • 1.4.5 CNS and Neurological Disorders
        • 1.4.6 Endocrinology
      • 1.5 Study Objectives
      • 1.6 Years Considered

      2 Global Growth Trends

      • 2.1 Global Active Pharmaceutical Ingredients(API) Market Size
        • 2.1.1 Global Active Pharmaceutical Ingredients(API) Revenue 2014-2025
        • 2.1.2 Global Active Pharmaceutical Ingredients(API) Sales 2014-2025
      • 2.2 Active Pharmaceutical Ingredients(API) Growth Rate by Regions
        • 2.2.1 Global Active Pharmaceutical Ingredients(API) Sales by Regions 2014-2019
        • 2.2.2 Global Active Pharmaceutical Ingredients(API) Revenue by Regions 2014-2019
      • 2.3 Industry Trends
        • 2.3.1 Market Top Trends
        • 2.3.2 Market Drivers

      3 Market Share by Manufacturers

      • 3.1 Active Pharmaceutical Ingredients(API) Sales by Manufacturers
        • 3.1.1 Active Pharmaceutical Ingredients(API) Sales by Manufacturers 2014-2019
        • 3.1.2 Active Pharmaceutical Ingredients(API) Sales Market Share by Manufacturers 2014-2019
      • 3.2 Revenue by Manufacturers
        • 3.2.1 Active Pharmaceutical Ingredients(API) Revenue by Manufacturers (2014-2019)
        • 3.2.2 Active Pharmaceutical Ingredients(API) Revenue Share by Manufacturers (2014-2019)
        • 3.2.3 Global Active Pharmaceutical Ingredients(API) Market Concentration Ratio (CR5 and HHI)
      • 3.3 Active Pharmaceutical Ingredients(API) Price by Manufacturers
      • 3.4 Key Manufacturers Active Pharmaceutical Ingredients(API) Plants/Factories Distribution and Area Served
      • 3.5 Date of Key Manufacturers Enter into Active Pharmaceutical Ingredients(API) Market
      • 3.6 Key Manufacturers Active Pharmaceutical Ingredients(API) Product Offered
      • 3.7 Mergers & Acquisitions, Expansion Plans

      4 Market Size by Type

      • 4.1 Sales and Revenue for Each Type
        • 4.1.1 Synthetic APIs Sales and Revenue (2014-2019)
        • 4.1.2 Biotech APIs Sales and Revenue (2014-2019)
      • 4.2 Global Active Pharmaceutical Ingredients(API) Sales Market Share by Type
      • 4.3 Global Active Pharmaceutical Ingredients(API) Revenue Market Share by Type
      • 4.4 Active Pharmaceutical Ingredients(API) Price by Type

      5 Market Size by Application

      • 5.1 Overview
      • 5.2 Global Active Pharmaceutical Ingredients(API) Sales by Application

      6 United States

      • 6.1 United States Active Pharmaceutical Ingredients(API) Breakdown Data by Company
      • 6.2 United States Active Pharmaceutical Ingredients(API) Breakdown Data by Type
      • 6.3 United States Active Pharmaceutical Ingredients(API) Breakdown Data by Application

      7 European Union

      • 7.1 European Union Active Pharmaceutical Ingredients(API) Breakdown Data by Company
      • 7.2 European Union Active Pharmaceutical Ingredients(API) Breakdown Data by Type
      • 7.3 European Union Active Pharmaceutical Ingredients(API) Breakdown Data by Application

      8 China

      • 8.1 China Active Pharmaceutical Ingredients(API) Breakdown Data by Company
      • 8.2 China Active Pharmaceutical Ingredients(API) Breakdown Data by Type
      • 8.3 China Active Pharmaceutical Ingredients(API) Breakdown Data by Application

      9 Rest of World

      • 9.1 Rest of World Active Pharmaceutical Ingredients(API) Breakdown Data by Company
      • 9.2 Rest of World Active Pharmaceutical Ingredients(API) Breakdown Data by Type
      • 9.3 Rest of World Active Pharmaceutical Ingredients(API) Breakdown Data by Application
      • 9.4 Rest of World Active Pharmaceutical Ingredients(API) Breakdown Data by Countries
        • 9.4.1 Rest of World Active Pharmaceutical Ingredients(API) Sales by Countries
        • 9.4.2 Rest of World Active Pharmaceutical Ingredients(API) Revenue by Countries
        • 9.4.3 Japan
        • 9.4.4 Korea
        • 9.4.5 India
        • 9.4.6 Southeast Asia

      10 Company Profiles

      • 10.1 Pfizer
        • 10.1.1 Pfizer Company Details
        • 10.1.2 Company Description and Business Overview
        • 10.1.3 Sales, Revenue and Market Share of Active Pharmaceutical Ingredients(API)
        • 10.1.4 Active Pharmaceutical Ingredients(API) Product Introduction
        • 10.1.5 Pfizer Recent Development
      • 10.2 Novartis International
        • 10.2.1 Novartis International Company Details
        • 10.2.2 Company Description and Business Overview
        • 10.2.3 Sales, Revenue and Market Share of Active Pharmaceutical Ingredients(API)
        • 10.2.4 Active Pharmaceutical Ingredients(API) Product Introduction
        • 10.2.5 Novartis International Recent Development
      • 10.3 Sanofi
        • 10.3.1 Sanofi Company Details
        • 10.3.2 Company Description and Business Overview
        • 10.3.3 Sales, Revenue and Market Share of Active Pharmaceutical Ingredients(API)
        • 10.3.4 Active Pharmaceutical Ingredients(API) Product Introduction
        • 10.3.5 Sanofi Recent Development
      • 10.4 Boehringer Ingelheim
        • 10.4.1 Boehringer Ingelheim Company Details
        • 10.4.2 Company Description and Business Overview
        • 10.4.3 Sales, Revenue and Market Share of Active Pharmaceutical Ingredients(API)
        • 10.4.4 Active Pharmaceutical Ingredients(API) Product Introduction
        • 10.4.5 Boehringer Ingelheim Recent Development
      • 10.5 Bristol-Myers Squibb
        • 10.5.1 Bristol-Myers Squibb Company Details
        • 10.5.2 Company Description and Business Overview
        • 10.5.3 Sales, Revenue and Market Share of Active Pharmaceutical Ingredients(API)
        • 10.5.4 Active Pharmaceutical Ingredients(API) Product Introduction
        • 10.5.5 Bristol-Myers Squibb Recent Development
      • 10.6 Teva Pharmaceutical
        • 10.6.1 Teva Pharmaceutical Company Details
        • 10.6.2 Company Description and Business Overview
        • 10.6.3 Sales, Revenue and Market Share of Active Pharmaceutical Ingredients(API)
        • 10.6.4 Active Pharmaceutical Ingredients(API) Product Introduction
        • 10.6.5 Teva Pharmaceutical Recent Development
      • 10.7 Eli Lilly and Company
        • 10.7.1 Eli Lilly and Company Company Details
        • 10.7.2 Company Description and Business Overview
        • 10.7.3 Sales, Revenue and Market Share of Active Pharmaceutical Ingredients(API)
        • 10.7.4 Active Pharmaceutical Ingredients(API) Product Introduction
        • 10.7.5 Eli Lilly and Company Recent Development
      • 10.8 GlaxoSmithKline
        • 10.8.1 GlaxoSmithKline Company Details
        • 10.8.2 Company Description and Business Overview
        • 10.8.3 Sales, Revenue and Market Share of Active Pharmaceutical Ingredients(API)
        • 10.8.4 Active Pharmaceutical Ingredients(API) Product Introduction
        • 10.8.5 GlaxoSmithKline Recent Development
      • 10.9 Merck & Co
        • 10.9.1 Merck & Co Company Details
        • 10.9.2 Company Description and Business Overview
        • 10.9.3 Sales, Revenue and Market Share of Active Pharmaceutical Ingredients(API)
        • 10.9.4 Active Pharmaceutical Ingredients(API) Product Introduction
        • 10.9.5 Merck & Co Recent Development
      • 10.10 AbbVie
        • 10.10.1 AbbVie Company Details
        • 10.10.2 Company Description and Business Overview
        • 10.10.3 Sales, Revenue and Market Share of Active Pharmaceutical Ingredients(API)
        • 10.10.4 Active Pharmaceutical Ingredients(API) Product Introduction
        • 10.10.5 AbbVie Recent Development
      • 10.11 Johnson & Johnson
      • 10.12 Bayer
      • 10.13 Sun Pharmaceutical Industries
      • 10.14 DSM
      • 10.15 Hisun Pharmacy
      • 10.16 Huahai Pharmaceutical
      • 10.17 North China Pharmaceutical Group
      • 10.18 Shandong Lukang Pharmaceutical
      • 10.19 Haerbin Pharmaceutical Group
      • 10.20 Shandong Xinhua Pharmaceutical
      • 10.21 Jiangsu Hengrui Medicine
      • 10.22 Lonza Group
      • 10.23 Aurobindo Pharma
      • 10.24 Lupin
      • 10.25 Biocon

      11 Value Chain and Sales Channels Analysis

      • 11.1 Value Chain Analysis
      • 11.2 Sales Channels Analysis
        • 11.2.1 Active Pharmaceutical Ingredients(API) Sales Channels
        • 11.2.2 Active Pharmaceutical Ingredients(API) Distributors
      • 11.3 Active Pharmaceutical Ingredients(API) Customers

      12 Market Forecast

      • 12.1 Global Active Pharmaceutical Ingredients(API) Sales and Revenue Forecast 2019-2025
      • 12.2 Global Active Pharmaceutical Ingredients(API) Sales Forecast by Type
      • 12.3 Global Active Pharmaceutical Ingredients(API) Sales Forecast by Application
      • 12.4 Active Pharmaceutical Ingredients(API) Forecast by Regions
        • 12.4.1 Global Active Pharmaceutical Ingredients(API) Sales Forecast by Regions 2019-2025
        • 12.4.2 Global Active Pharmaceutical Ingredients(API) Revenue Forecast by Regions 2019-2025
      • 12.5 United States Market Forecast
      • 12.6 European Union Market Forecast
      • 12.7 China Market Forecast
      • 12.8 Rest of World
        • 12.8.1 Japan
        • 12.8.2 Korea
        • 12.8.3 India

      13 Research Findings and Conclusion

        14 Appendix

        • 14.1 Research Methodology
          • 14.1.1 Methodology/Research Approach
            • 14.1.1.1 Research Programs/Design
            • 14.1.1.2 Market Size Estimation
            • 14.1.1.3 Market Breakdown and Data Triangulation
          • 14.1.2 Data Source
            • 14.1.2.1 Secondary Sources
            • 14.1.2.2 Primary Sources
        • 14.2 Author Details

        In 2019, the market size of Active Pharmaceutical Ingredients(API) is million US$ and it will reach million US$ in 2025, growing at a CAGR of from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
        In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Active Pharmaceutical Ingredients(API).

        This report studies the global market size of Active Pharmaceutical Ingredients(API), especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
        This study presents the Active Pharmaceutical Ingredients(API) sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
        For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

        In global market, the following companies are covered:
        Pfizer
        Novartis International
        Sanofi
        Boehringer Ingelheim
        Bristol-Myers Squibb
        Teva Pharmaceutical
        Eli Lilly and Company
        GlaxoSmithKline
        Merck & Co
        AbbVie
        Johnson & Johnson
        Bayer
        Sun Pharmaceutical Industries
        DSM
        Hisun Pharmacy
        Huahai Pharmaceutical
        North China Pharmaceutical Group
        Shandong Lukang Pharmaceutical
        Haerbin Pharmaceutical Group
        Shandong Xinhua Pharmaceutical
        Jiangsu Hengrui Medicine
        Lonza Group
        Aurobindo Pharma
        Lupin
        Biocon

        Market Segment by Product Type
        Synthetic APIs
        Biotech APIs

        Market Segment by Application
        Oncology
        Diabetes
        Cardiovascular Disease
        CNS and Neurological Disorders
        Endocrinology

        Key Regions split in this report: breakdown data for each region.
        United States
        China
        European Union
        Rest of World (Japan, Korea, India and Southeast Asia)

        The study objectives are:
        To analyze and research the Active Pharmaceutical Ingredients(API) status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
        To present the key Active Pharmaceutical Ingredients(API) manufacturers, presenting the sales, revenue, market share, and recent development for key players.
        To split the breakdown data by regions, type, companies and applications
        To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
        To identify significant trends, drivers, influence factors in global and regions
        To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

        In this study, the years considered to estimate the market size of Active Pharmaceutical Ingredients(API) are as follows:
        History Year: 2014-2018
        Base Year: 2018
        Estimated Year: 2019
        Forecast Year 2019 to 2025



        Summary:
        Active Pharmaceutical Ingredients(API) Market Research Report is Active Pharmaceutical Ingredients(API) Market Report. Get Active Pharmaceutical Ingredients(API) market research reports for Market Research, Analysis, Trends & Statistics. Latest Industry findings, analysis and Market Report on Active Pharmaceutical Ingredients(API) . Active Pharmaceutical Ingredients(API) Market Report is a syndicated market report to understand, Market Demand, Growth, trends analysis and Factor Influencing market in upcoming years.



        REPORT YOU MIGHT BE INTERESTED